Assenagon Asset Management S.A. Syros Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$3.26 - $4.66 $283,857 - $405,760	-87,073 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$4.08 - $5.66 $117,144 - $162,509	-28,712 Reduced 24.8%	87,073 $389,000
Q2 2021 Jul 15, 2021	BUY	$5.01 - $7.48 $580,082 - $866,071	115,785 New	115,785 $631,000
Q2 2019 Aug 12, 2019	SELL	$5.5 - $9.75 $189,750 - $336,375	-34,500 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$5.51 - $9.59 $306,895 - $534,143	-55,698 Reduced 61.75%	34,500 $315,000
Q4 2018 Jan 23, 2019	BUY	$5.55 - $11.34 $500,598 - $1.02 Million	90,198 New	90,198 $502,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.